The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
Great advances have been made in describing the intracellular pathways and genes that are activated by bacterial products. New definitions and therapies for sepsis will be based on such cellular and genetic alterations. In particular, in 2051 sepsis will no longer be defined simply as a clinical con...
保存先:
| 出版年: | Crit Care |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2002
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137301/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12225594/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc1506 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|